Rivo Health review
Rivo Health is a large nationwide GLP-1 telehealth program (115,000+ members, Trustpilot 4.7) offering compounded semaglutide and tirzepatide as both injections and oral options, starting around $149/mo for…
Est. first month
From $149/mo (compounded)
- Semaglutide
- From $149/mo (compounded)
- Tirzepatide
- From $199/mo (compounded)
- Coverage
- All 50 states
- Brand-name
- Compounded only
The Value Score card
Rivo Health scored on our six published factors. See the methodology.
Why it's a deal
- Compounded semaglutide and tirzepatide as both injections and oral options, starting around $149/mo (sema) and $199/mo (tirz)
- Bundles dietitians, live workouts, support groups and mental-health coaching with the medication, not just a prescription
- Insurance concierge to maximize coverage, FSA/HSA eligible, with multi-month plans that cut the price further
- Large, established program (115,000+ members, Trustpilot 4.7) available nationwide
Read the fine print
- Uses partner compounding pharmacies it doesn't name on the site
- Headline prices are Spring-sale rates — everyday cost is higher and the deepest discounts need a 6-month commitment
- Weight loss is one of several verticals (ED, longevity, sleep, hair, skin), not a single focus
- Some bundled perks (e.g. meal prep) are paid add-ons rather than included
The bottom line
Best for: People who want injectable or oral compounded GLP-1 bundled with coaching and insurance-concierge support. Rivo Health is a large nationwide GLP-1 telehealth program (115,000+ members, Trustpilot 4.7) offering compounded semaglutide and tirzepatide as both injections and oral options, starting around $149/mo for…
Ranked #58 of 395 programs we track — see our #1 deal, CoreAge Rx, for comparison.
Compare with other deals
The programs scoring closest to Rivo Health, out of 394 others we track.
Shopping Rivo Health against a specific rival? We put it head to head with our top-scoring pick on CoreAge Rx vs Rivo Health, and every program that undercuts or outscores it is ranked on the Rivo Health alternatives board.
- From $199/mo (compounded oral)Curex— Curex (Curex, Inc.) offers compounded semaglutide ($149/mo) and tirzepatide ($199/mo) in injectable and oral dissolving tablet formats.81/100
- $179/moGOAL.MD— GOAL.MD is a St. Louis-based telehealth platform offering compounded semaglutide alongside brand-name bridges to Ozempic, Wegovy, and Zepbound. Its standout is a manual-renewal model — no auto-billing81/100
- From $99/mo (12-month plan, compounded)MyFastRx— MyFastRx is a cash-pay compounded-GLP-1 platform built around fast approval and discounted multi-month bundles.81/100
- From $119/mo (3-month plan, compounded)Trillium Meds— Trillium Meds is a small, owner-operated telehealth platform based in Portland, OR that connects patients with independent licensed providers and FDA-registered compounding pharmacies for compounded…81/100
- From $119/mo (compounded oral)Tyde Wellness— Tyde Wellness is a 50-state compounded-GLP-1 and longevity telehealth platform spanning weight loss, HRT, hair, and peptides.81/100
- $239/moEden— The priciest of the top programs we track, but the most transparent — you pay up, never get baited.81/100
More programs we track (24)
- #1 CoreAge Rx93
- #2 Ondra Health92
- #4 Vitara RX91
- #5 Gimme Care91
- #7 Alan Meds90
- #3 Trimi Health89
- #10 Precision Telemed89
- #11 bmiMD89
- #12 Care Clinics89
- #6 Oak88
- #16 Live Vital88
- #17 AmberHealth88
- #18 Fresh Day Meds88
- #8 Sesame Care87
- #9 Strut Health87
- #22 EverSlim87
- #23 NewSelf87
- #24 Vaylen87
- #25 Mint Med87
- #13 HealthRX86
- #14 RxSpan MD86
- #15 Sprout Health86
- #28 Bionomy Health86
- #29 BetterMe Rx86
364 more are reviewed too — see every GLP-1 program we track, ranked.
Pricing and coverage on this page were read from Rivo Health's own website on ; the Value Score is our editorial judgment per the methodology. “% vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on Rivo Health's site. Not medical advice; see our disclosure.